Biostax Corp.
BTAX · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|
| Market Cap | $0 | $0 | $0 |
| - Cash | $0 | -$0 | $0 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | $0 | -$0 | -$0 |
| % Margin | – | – | – |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | – | – | – |
| EPS Diluted | -0.001 | -0.01 | -0.004 |
| % Growth | 95% | -138.1% | – |
| Operating Cash Flow | – | – | -$0 |
| Capital Expenditures | – | – | $0 |
| Free Cash Flow | – | – | -$0 |